BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Gastroenterology and Hepatology - Immunology - Pediatrics and Child Health

Fc-Epsilon-RI, the High Affinity IgE-Receptor, Is Robustly Expressed in the Upper Gastrointestinal Tract and Modulated by Mucosal Inflammation
Published: Friday, July 27, 2012
Author: Christina Bannert et al.

by Christina Bannert, Bettina Bidmon-Fliegenschnee, Georg Stary, Florian Hotzy, Judith Stift, Samuel Nurko, Zsolt Szépfalusi, Edda Fiebiger, Eleonora Dehlink

Background

The role of the high affinity IgE receptor, FceRI, in IgE-mediated immune responses of the gastrointestinal (GI) mucosa is poorly understood. Currently, a detailed characterization of FceRI expression throughout the human gut is lacking. The aim of this study was to define the expression pattern of FceRI in the GI tract.

Methods/Principal Findings

We compared FceRI expression in children with gastritis/esophagitis (n?=?10), celiac disease (n?=?10), inflammatory bowel disease (IBD) (n?=?9), and normal mucosa (n?=?5). The a–subunit of FceRI (FceRIa), detected by immunohistochemistry, was found on cells infiltrating the mucosa of the esophagus, the stomach, and the duodenum, but was rarely detected in more distal sections of the GI tract. Accordingly, quantitative RT-PCR analysis on esophagus, stomach, duodenum, colon, and rectum biopsies revealed that FceRIa and -ß expression levels decreased towards the distal intestine. mRNA transcripts of the common Fc-receptor-? chain were present in the entire GI mucosa. Double-immunofluorescence staining of esophageal specimens confirmed that FceRIa was expressed on intraepithelial mast cells and Langerhans cells. The mRNA expression levels of the a, ß, and ? subunits of FceRI did not correlate with total serum IgE but were associated with mucosal inflammation.

Conclusion/Significance

Our data define the upper GI tract as the main site for IgE-mediated immune activation via FceRI. Tissue mRNA levels of FceRIa are regulated by inflammatory conditions rather than serum IgE, indicating that FceRI might also play a role in pathologies other than allergy.

  More...